| Company Name: |
Pharmalego |
| Tel: |
18321033991 |
| Email: |
marketing@pharmalego.com |
|
| | N-(9-[(2R,3R,4R,5R)-5-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-3-fluoro-4-hydroxy-3-methyloxolan-2-yl]-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-methylpropanamide Basic information |
| | N-(9-[(2R,3R,4R,5R)-5-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-3-fluoro-4-hydroxy-3-methyloxolan-2-yl]-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-methylpropanamide Chemical Properties |
| density | 1.35±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 8.68±0.20(predicted) |
| | N-(9-[(2R,3R,4R,5R)-5-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-3-fluoro-4-hydroxy-3-methyloxolan-2-yl]-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-methylpropanamide Usage And Synthesis |
| | N-(9-[(2R,3R,4R,5R)-5-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-3-fluoro-4-hydroxy-3-methyloxolan-2-yl]-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-methylpropanamide Preparation Products And Raw materials |
|